Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colitis, Ulcerative 3Arthritis, Rheumatoid 3Spondylitis, Ankylosing 1Recurrence 1Prostatic Neoplasms 1Lymphoma 1Inflammatory Bowel Diseases 1Diabetes Mellitus, Type 1 1Crohn Disease 1

Interventions

etrolizumab 5Infliximab 4Adalimumab 4golimumab 3Nivolumab 3Specimen Handling 2Colonoscopy 2CT-P13 2pembrolizumab 1peficitinib 1cabozantinib 1Vitamin E 1Sutures 1Surgical Instruments 1Ringer's Lactate 1Proctectomy 1Pneumococcal Vaccines 1Platinum Compounds 1Papillomavirus Vaccines 1Narrow Band Imaging 1NX-13 1Methylprednisolone 1Mesalamine 1Medical Marijuana 1Lysine Acetyltransferase 5 1Loperamide 1Iron-Dextran Complex 1Ipilimumab 1Injections 1Indigo Carmine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Colitis, Ulcerative × golimumab × Clear all
NCT03011268 2025-05-31

BIOSTOP

Helse Møre og Romsdal HF

Phase NA Completed
174 enrolled

Colitis, Ulcerative, Recurrence

NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT02186886 2014-07-10

Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab

Kliniken im Naturpark Altmuehltal

Phase 4 Unknown
50 enrolled

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡